Evidence map›Paper›PMID 25774804›Full record

ArticlePloS one2015

Risk factors for death from Influenza A(H1N1)pdm09, State of São Paulo, Brazil, 2009.

Ana Freitas Ribeiro, Alessandra Cristina Guedes Pellini, Beatriz Yuko Kitagawa, Daniel Marques, Geraldine Madalosso, Gerrita de Cassia Nogueira Figueira, João Fred, Ricardo Kerti Mangabeira Albernaz, Telma Regina Marques Pinto Carvalhanas, Dirce Maria Trevisan Zanetta

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Impact of severe hematological abnormalities in the outcome of hospitalized patients with influenza virus infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Observational
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ana Freitas RibeiroEpidemiological Surveillance Center, Disease Control Coordination, State of São Paulo Department of Health, São Paulo, Brazil; Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, Brazil.
Alessandra Cristina Guedes PelliniEpidemiological Surveillance Center, Disease Control Coordination, State of São Paulo Department of Health, São Paulo, Brazil.
Beatriz Yuko KitagawaEpidemiological Surveillance Center, Disease Control Coordination, State of São Paulo Department of Health, São Paulo, Brazil.
Daniel MarquesEpidemiological Surveillance Center, Disease Control Coordination, State of São Paulo Department of Health, São Paulo, Brazil.
Geraldine MadalossoEpidemiological Surveillance Center, Disease Control Coordination, State of São Paulo Department of Health, São Paulo, Brazil.
Gerrita de Cassia Nogueira FigueiraEpidemiological Surveillance Center, Disease Control Coordination, State of São Paulo Department of Health, São Paulo, Brazil.
João FredEpidemiological Surveillance Center, Disease Control Coordination, State of São Paulo Department of Health, São Paulo, Brazil.
Ricardo Kerti Mangabeira AlbernazEpidemiological Surveillance Center, Disease Control Coordination, State of São Paulo Department of Health, São Paulo, Brazil.
Telma Regina Marques Pinto CarvalhanasEpidemiological Surveillance Center, Disease Control Coordination, State of São Paulo Department of Health, São Paulo, Brazil.
Dirce Maria Trevisan ZanettaDepartment of Epidemiology, School of Public Health, University of São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case-control study aimed to assess the risk factors for death from influenza A(H1N1)pdm09 in patients with laboratory confirmation, who had severe acute respiratory illness-SARI and were hospitalized between June 28th and August 29th 2009, in the metropolitan regions of São Paulo and Campinas, Brazil. Medical charts of all the 193 patients who died (cases) and the 386 randomly selected patients who recovered (controls) were investigated in 177 hospitals. Household interviews were conducted with those who had survived and the closest relative of those who had died. 73.6% of cases and 38.1% of controls were at risk of developing influenza-related complications. The 18-to-59-year age group (OR = 2.31, 95%CI: 1.31-4.10 (reference up to 18 years of age)), presence of risk conditions for severity of influenza (OR = 1.99, 95%CI: 1.11-3.57, if one or OR = 6.05, 95%CI: 2.76-13.28, if more than one), obesity (OR = 2.73, 95%CI: 1.28-5.83), immunosuppression (OR = 3.43, 95%CI: 1.28-9.19), and search for previous care associated with the hospitalization (OR = 3.35, 95%CI: 1.75-6.40) were risk factors for death. Antiviral treatment performed within 72 hours of the onset of symptoms (OR = 0.17, 95%CI: 0.08-0.37, if within 48hours, and OR = 0.30, 95%CI: 0.11-0.81, if between 48 and 72 hours) was protective against death. The identification of high-risk patients and early treatment are important factors for reducing morbi-mortality from influenza.

Indexed as

AdolescentAdultAntiviral AgentsBrazilCase-Control StudiesDeathFemaleHospitalizationHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMaleMiddle AgedPrognosisRisk FactorsYoung AdultAntiviral Agents

Identifiers

PMID25774804
PMCPMC4361171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.